Skip to content

Evoke Pharma in distribution deal for Gimoti

September 3, 2020

Evoke Pharma (NASDAQ:EVOK) has entered into a sales and distribution agreement with Eversana Life Science Services, as contemplated by the commercial services agreement dated January 2020.

Under the terms of the agreement, the Company will supply Eversana with all of the requirements for Gimoti (metoclopramide) nasal spray.

Eversana will also provide certain order to cash, chargeback processing, government price reporting, and logistics services pursuant to the agreement.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: